Treatment Recommendation for Sore, Red, Tender Skin Lesion
For a sore, red, and tender skin lesion concerning for bacterial skin infection (furuncle/carbuncle), I recommend oral antibiotics targeting MRSA coverage with trimethoprim-sulfamethoxazole 1-2 double-strength tablets twice daily or doxycycline 100 mg twice daily, combined with incision and drainage if fluctuant.
Clinical Assessment and Treatment Algorithm
Step 1: Determine if This is an Infection vs. Inflammatory Condition
A "skin pump" that is sore, red, and tender most likely represents:
- Bacterial skin infection (furuncle, carbuncle, or abscess) - most common
- Less likely: inflammatory dermatosis requiring different treatment
Key distinguishing features to look for:
- Infection indicators: Warmth, fluctuance, purulent drainage, fever, rapid onset
- Inflammatory indicators: Chronic course, scaling, bilateral distribution, no purulence
Step 2: If Bacterial Infection - Choose Antibiotic Based on Severity
The IDSA guidelines 1 provide clear treatment pathways:
For Mild-Moderate Infection (No Systemic Signs):
First-line oral options:
- Trimethoprim-sulfamethoxazole: 1-2 double-strength tablets twice daily
- Doxycycline or minocycline: 100 mg twice daily
- Clindamycin: 300-450 mg four times daily (if local resistance patterns allow)
These agents provide MRSA coverage, which is critical given community-acquired MRSA prevalence 1.
For Severe Infection (SIRS criteria present):
If the patient has fever >38°C or <36°C, tachycardia >90 bpm, tachypnea >24 breaths/min, or WBC >12,000 or <4,000 cells/μL:
Parenteral options:
- Vancomycin: 30 mg/kg/day in 2 divided doses IV (drug of choice for MRSA)
- Linezolid: 600 mg every 12 hours IV or PO
- Daptomycin: 4 mg/kg every 24 hours IV
- Ceftaroline: 600 mg twice daily IV
Step 3: Duration and Adjunctive Measures
- Treatment duration: Typically 5-10 days for uncomplicated infections
- Incision and drainage: Essential if fluctuant abscess present - antibiotics alone are insufficient
- Reassess at 48-72 hours: If no improvement, consider drainage, culture, or antibiotic adjustment
Important Clinical Pitfalls
Do NOT use these for suspected bacterial skin infection:
- Cephalexin or dicloxacillin alone - these lack MRSA coverage and are only appropriate for confirmed MSSA
- Topical corticosteroids - will worsen bacterial infections
- Amoxicillin-clavulanate monotherapy - inadequate MRSA coverage
Common mistake: The guideline 1 shows that older agents like cephalexin (500 mg four times daily) or dicloxacillin (500 mg four times daily) are only appropriate for confirmed methicillin-susceptible S. aureus (MSSA). Given the high prevalence of community MRSA, empiric coverage should target MRSA until culture results are available.
If This is NOT an Infection
If clinical features suggest inflammatory dermatosis (eczema, contact dermatitis) rather than infection, the approach differs entirely - topical corticosteroids would be appropriate, but this seems unlikely given your description of a single sore, red, tender lesion rather than a chronic inflammatory condition.